A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

  • Jiraborrirak Charoenpattarapreeda
  • Werner Tegge
  • Chunfa Xu
  • Kirsten Harmrolfs
  • Bettina Hinkelmann
  • Hannah Wullenkord
  • Sven Kevin Hotop
  • Ulrike Beutling
  • Katharina Rox
  • Mark Brönstrup

Externe Organisationen

  • Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
  • Deutsches Zentrum für Infektionsforschung (DZIF)
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Aufsatznummere202408360
Seitenumfang8
FachzeitschriftAngewandte Chemie - International Edition
Jahrgang63
Ausgabenummer47
Frühes Online-Datum8 Aug. 2024
PublikationsstatusVeröffentlicht - 11 Nov. 2024

Abstract

The use of highly potent but very toxic antibiotics such as colistin has become inevitable due to the rise of antimicrobial resistance. We aimed for a chemically-triggered, controlled release of colistin at the infection site to lower its systemic toxicity by harnessing the power of click-to-release reactions. Kinetic experiments with nine tetrazines and three dienophiles demonstrated a fast release via an inverse-electron-demand Diels–Alder reaction between trans-cyclooctene (TCO) and the amine-functionalised tetrazine Tz7. The antibiotic activity of colistin against Escherichia coli was masked by TCO units, but restored upon reaction with d-Ubi−Tz, a tetrazine functionalised with the bacterial binding peptide d-Ubi29–41. While standard TCO did not improve toxicity against human proximal tubular kidney HK-2 cells, the installation of an aspartic acid-modified TCO masking group reduced the overall charge of the peptide and entry to the kidney cells, thereby dramatically lowering its toxicity. The analog Col−(TCO-Asp)1 had favourable pharmacokinetic properties in mice and was successfully activated locally in the lung by d-Ubi−Tz in an in vivo infection model, whereas it remained inactive and non-harmful without the chemical trigger. This study constitutes the first example of a systemically acting two-component antibiotic with improved drug tolerability.

ASJC Scopus Sachgebiete

Zitieren

A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. / Charoenpattarapreeda, Jiraborrirak; Tegge, Werner; Xu, Chunfa et al.
in: Angewandte Chemie - International Edition, Jahrgang 63, Nr. 47, e202408360, 11.11.2024.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Charoenpattarapreeda, J, Tegge, W, Xu, C, Harmrolfs, K, Hinkelmann, B, Wullenkord, H, Hotop, SK, Beutling, U, Rox, K & Brönstrup, M 2024, 'A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity', Angewandte Chemie - International Edition, Jg. 63, Nr. 47, e202408360. https://doi.org/10.1002/anie.202408360
Charoenpattarapreeda, J., Tegge, W., Xu, C., Harmrolfs, K., Hinkelmann, B., Wullenkord, H., Hotop, S. K., Beutling, U., Rox, K., & Brönstrup, M. (2024). A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. Angewandte Chemie - International Edition, 63(47), Artikel e202408360. https://doi.org/10.1002/anie.202408360
Charoenpattarapreeda J, Tegge W, Xu C, Harmrolfs K, Hinkelmann B, Wullenkord H et al. A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. Angewandte Chemie - International Edition. 2024 Nov 11;63(47):e202408360. Epub 2024 Aug 8. doi: 10.1002/anie.202408360
Charoenpattarapreeda, Jiraborrirak ; Tegge, Werner ; Xu, Chunfa et al. / A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. in: Angewandte Chemie - International Edition. 2024 ; Jahrgang 63, Nr. 47.
Download
@article{f84b7ba4e5d34ffaaa886409c2a20c1f,
title = "A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity",
abstract = "The use of highly potent but very toxic antibiotics such as colistin has become inevitable due to the rise of antimicrobial resistance. We aimed for a chemically-triggered, controlled release of colistin at the infection site to lower its systemic toxicity by harnessing the power of click-to-release reactions. Kinetic experiments with nine tetrazines and three dienophiles demonstrated a fast release via an inverse-electron-demand Diels–Alder reaction between trans-cyclooctene (TCO) and the amine-functionalised tetrazine Tz7. The antibiotic activity of colistin against Escherichia coli was masked by TCO units, but restored upon reaction with d-Ubi−Tz, a tetrazine functionalised with the bacterial binding peptide d-Ubi29–41. While standard TCO did not improve toxicity against human proximal tubular kidney HK-2 cells, the installation of an aspartic acid-modified TCO masking group reduced the overall charge of the peptide and entry to the kidney cells, thereby dramatically lowering its toxicity. The analog Col−(TCO-Asp)1 had favourable pharmacokinetic properties in mice and was successfully activated locally in the lung by d-Ubi−Tz in an in vivo infection model, whereas it remained inactive and non-harmful without the chemical trigger. This study constitutes the first example of a systemically acting two-component antibiotic with improved drug tolerability.",
keywords = "antibiotics, bioorthogonal chemistry, drug conjugates, drug delivery, natural products",
author = "Jiraborrirak Charoenpattarapreeda and Werner Tegge and Chunfa Xu and Kirsten Harmrolfs and Bettina Hinkelmann and Hannah Wullenkord and Hotop, {Sven Kevin} and Ulrike Beutling and Katharina Rox and Mark Br{\"o}nstrup",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.",
year = "2024",
month = nov,
day = "11",
doi = "10.1002/anie.202408360",
language = "English",
volume = "63",
journal = "Angewandte Chemie - International Edition",
issn = "1433-7851",
publisher = "John Wiley and Sons Ltd",
number = "47",

}

Download

TY - JOUR

T1 - A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity

AU - Charoenpattarapreeda, Jiraborrirak

AU - Tegge, Werner

AU - Xu, Chunfa

AU - Harmrolfs, Kirsten

AU - Hinkelmann, Bettina

AU - Wullenkord, Hannah

AU - Hotop, Sven Kevin

AU - Beutling, Ulrike

AU - Rox, Katharina

AU - Brönstrup, Mark

N1 - Publisher Copyright: © 2024 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

PY - 2024/11/11

Y1 - 2024/11/11

N2 - The use of highly potent but very toxic antibiotics such as colistin has become inevitable due to the rise of antimicrobial resistance. We aimed for a chemically-triggered, controlled release of colistin at the infection site to lower its systemic toxicity by harnessing the power of click-to-release reactions. Kinetic experiments with nine tetrazines and three dienophiles demonstrated a fast release via an inverse-electron-demand Diels–Alder reaction between trans-cyclooctene (TCO) and the amine-functionalised tetrazine Tz7. The antibiotic activity of colistin against Escherichia coli was masked by TCO units, but restored upon reaction with d-Ubi−Tz, a tetrazine functionalised with the bacterial binding peptide d-Ubi29–41. While standard TCO did not improve toxicity against human proximal tubular kidney HK-2 cells, the installation of an aspartic acid-modified TCO masking group reduced the overall charge of the peptide and entry to the kidney cells, thereby dramatically lowering its toxicity. The analog Col−(TCO-Asp)1 had favourable pharmacokinetic properties in mice and was successfully activated locally in the lung by d-Ubi−Tz in an in vivo infection model, whereas it remained inactive and non-harmful without the chemical trigger. This study constitutes the first example of a systemically acting two-component antibiotic with improved drug tolerability.

AB - The use of highly potent but very toxic antibiotics such as colistin has become inevitable due to the rise of antimicrobial resistance. We aimed for a chemically-triggered, controlled release of colistin at the infection site to lower its systemic toxicity by harnessing the power of click-to-release reactions. Kinetic experiments with nine tetrazines and three dienophiles demonstrated a fast release via an inverse-electron-demand Diels–Alder reaction between trans-cyclooctene (TCO) and the amine-functionalised tetrazine Tz7. The antibiotic activity of colistin against Escherichia coli was masked by TCO units, but restored upon reaction with d-Ubi−Tz, a tetrazine functionalised with the bacterial binding peptide d-Ubi29–41. While standard TCO did not improve toxicity against human proximal tubular kidney HK-2 cells, the installation of an aspartic acid-modified TCO masking group reduced the overall charge of the peptide and entry to the kidney cells, thereby dramatically lowering its toxicity. The analog Col−(TCO-Asp)1 had favourable pharmacokinetic properties in mice and was successfully activated locally in the lung by d-Ubi−Tz in an in vivo infection model, whereas it remained inactive and non-harmful without the chemical trigger. This study constitutes the first example of a systemically acting two-component antibiotic with improved drug tolerability.

KW - antibiotics

KW - bioorthogonal chemistry

KW - drug conjugates

KW - drug delivery

KW - natural products

UR - http://www.scopus.com/inward/record.url?scp=85206569302&partnerID=8YFLogxK

U2 - 10.1002/anie.202408360

DO - 10.1002/anie.202408360

M3 - Article

C2 - 39113573

AN - SCOPUS:85206569302

VL - 63

JO - Angewandte Chemie - International Edition

JF - Angewandte Chemie - International Edition

SN - 1433-7851

IS - 47

M1 - e202408360

ER -